Literature DB >> 15736429

Functional analysis of focal adhesion kinase (FAK) reduction by small inhibitory RNAs.

Edward Kyu-Ho Han1, Thomas Mcgonigal, Jieyi Wang, Vincent L Giranda, Yan Luo.   

Abstract

The focal adhesion kinase (FAK) is a non-receptor tyrosine kinase that localizes to the points of cell contact with the extracellular matrix, called focal adhesions. Many factors induce tyrosine phosphorylation of FAK including growth factors, neuropeptides and integrin-dependent adhesion to the extracellular matrix. FAK has been implicated in several cellular processes such as invasion, motility, proliferation and apoptosis. In addition, FAK expression was shown to be elevated in a number of different human cancers, suggesting a role in the development of malignancy. We examined the biological functions of FAK using small inhibitory RNAs (siRNA) in cancer cells. Although FAK siRNA reduced the FAK protein levels by approximately 70% in several cancer cell lines, there was no clear evidence of apoptosis. However, in clonogenic and soft-agar assays in H1299, a lung cancer cell line, FAK siRNA treatment led to a 43% to 55% decrease in colony formation. Furthermore, FAK siRNA-treated cells displayed a decrease in migration when serum or EGF (epidermal growth factor) were used as chemo-attractants. Our results demonstrated that inhibition of FAK protein leads to alterations in cell growth and migration.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15736429

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  17 in total

1.  Association between breast cancer cell migration and radiosensitivity in vitro.

Authors:  Jing Hou; Leilei Li; Haizhen Zhu; Huan Chen; Na Wei; Min Dai; Qing Ni; Xiaomao Guo
Journal:  Oncol Lett       Date:  2019-10-31       Impact factor: 2.967

2.  FAK Inhibition Decreases Hepatoblastoma Survival Both In Vitro and In Vivo.

Authors:  Lauren A Gillory; Jerry E Stewart; Michael L Megison; Hugh C Nabers; Elizabeth Mroczek-Musulman; Elizabeth A Beierle
Journal:  Transl Oncol       Date:  2013-04-01       Impact factor: 4.243

3.  FAK inhibition abrogates the malignant phenotype in aggressive pediatric renal tumors.

Authors:  Michael L Megison; Lauren A Gillory; Jerry E Stewart; Hugh C Nabers; Elizabeth Mrozcek-Musulman; Elizabeth A Beierle
Journal:  Mol Cancer Res       Date:  2014-01-24       Impact factor: 5.852

4.  Inhibition of the focal adhesion kinase and vascular endothelial growth factor receptor-3 interaction leads to decreased survival in human neuroblastoma cell lines.

Authors:  Elizabeth A Beierle; Xiaojie Ma; Jerry E Stewart; Michael Megison; William G Cance; Elena V Kurenova
Journal:  Mol Carcinog       Date:  2012-10-12       Impact factor: 4.784

5.  Inhibition of focal adhesion kinase and src increases detachment and apoptosis in human neuroblastoma cell lines.

Authors:  Elizabeth A Beierle; Xiaojie Ma; Angelica Trujillo; Elena V Kurenova; William G Cance; Vita M Golubovskaya
Journal:  Mol Carcinog       Date:  2010-03       Impact factor: 4.784

6.  FAK inhibition decreases cell invasion, migration and metastasis in MYCN amplified neuroblastoma.

Authors:  Michael L Megison; Jerry E Stewart; Hugh C Nabers; Lauren A Gillory; Elizabeth A Beierle
Journal:  Clin Exp Metastasis       Date:  2012-12-04       Impact factor: 5.150

7.  Construction of retroviral vector of p(125FAK) specific ribozyme genes and its effects on BGC-823 cells.

Authors:  Guo-Xian Guan; Hong-Xing Jian; Dong-Yin Lei; Hui-Shan Lu; Xiang-Fu Zhang
Journal:  World J Gastroenterol       Date:  2006-02-07       Impact factor: 5.742

8.  Expression of FAK and PTEN in bronchioloalveolar carcinoma and lung adenocarcinoma.

Authors:  Changli Wang; Ran Yang; Dongsheng Yue; Zhenfa Zhang
Journal:  Lung       Date:  2009-02-26       Impact factor: 2.584

9.  Inhibition of focal adhesion kinase decreases tumor growth in human neuroblastoma.

Authors:  Elizabeth A Beierle; Xiaojie Ma; Jerry Stewart; Carl Nyberg; Angelica Trujillo; William G Cance; Vita M Golubovskaya
Journal:  Cell Cycle       Date:  2010-03-14       Impact factor: 4.534

Review 10.  Focal adhesion kinase and p53 signal transduction pathways in cancer.

Authors:  Vita M Golubovskaya; William Cance
Journal:  Front Biosci (Landmark Ed)       Date:  2010-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.